Closed-Loop Blood Glucose Control Device (CBGCD)

The closed-loop blood glucose control device is covered for short-term (generally 24–48 hours) inpatient management of insulin-dependent (Type I) diabetic patients in crisis (e.g., trauma, surgery, labor/delivery) to stabilize wide glucose fluctuations and temporarily correct hyper- or hypoglycemia. Coverage requires use in the hospital inpatient setting under the direction and continuous observation of specially trained medical personnel, with device printouts and clinical documentation retained to support the episode of care.

"Covered for short-term management of insulin-dependent diabetes mellitus (Type I) in crisis situations when used in a hospital inpatient setting under the direction of specially trained medical per..."

Sign up to see full coverage criteria, indications, and limitations.